Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 5-6/2013

01.03.2013 | review article

Chemotherapy of vulvar cancer: a review

verfasst von: MD Gunter Deppe, MD Ismail Mert, MD Jimmy Belotte, MD, PhD Ira S. Winer

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 5-6/2013

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Squamous cell carcinoma of the vulva is a rare disease with good prognosis if diagnosed early. The standard primary therapy is surgery. Neoadjuvant radiation or chemotherapy has been used to achieve resectability of the tumor and to decrease the radicality of the surgery. Chemotherapy with platinum compounds, paclitaxel and targeted therapy (erlotinib) has shown activity. International collaborative trials are needed to identify the best therapeutic strategy for patients with squamous cell cancer of the vulva who are not candidates for primary surgery or concomitant chemoradiation. We review the various treatment options available to patients with advanced or recurrent squamous cell cancer of the vulva.
Literatur
1.
Zurück zum Zitat Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. PubMedCrossRef Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. PubMedCrossRef
2.
Zurück zum Zitat Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based case-control study in Denmark. Int J Cancer. 2008;122:2827–34. PubMedCrossRef Madsen BS, Jensen HL, van den Brule AJ, Wohlfahrt J, Frisch M. Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based case-control study in Denmark. Int J Cancer. 2008;122:2827–34. PubMedCrossRef
3.
Zurück zum Zitat Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109:340–5. PubMedCrossRef Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG. New aspects of vulvar cancer: changes in localization and age of onset. Gynecol Oncol. 2008;109:340–5. PubMedCrossRef
4.
Zurück zum Zitat Farias-Eisner R, Berek JS. Current management of invasive squamous carcinoma of the vulva. Clin Geriatr Med. 1993;9:131–43. PubMed Farias-Eisner R, Berek JS. Current management of invasive squamous carcinoma of the vulva. Clin Geriatr Med. 1993;9:131–43. PubMed
5.
Zurück zum Zitat Hoffman MS. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol. 2003;17:635–47. PubMedCrossRef Hoffman MS. Squamous-cell carcinoma of the vulva: locally advanced disease. Best Pract Res Clin Obstet Gynaecol. 2003;17:635–47. PubMedCrossRef
6.
Zurück zum Zitat Hacker NF, Van der Velden J. 1993. Conservative management of early vulvar cancer. Cancer. 71:1673–7. PubMedCrossRef Hacker NF, Van der Velden J. 1993. Conservative management of early vulvar cancer. Cancer. 71:1673–7. PubMedCrossRef
7.
Zurück zum Zitat Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the gynecologic oncology group. Obstet Gynecol. 1992;79:490–7. PubMed Stehman FB, Bundy BN, Dvoretsky PM, Creasman WT. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the gynecologic oncology group. Obstet Gynecol. 1992;79:490–7. PubMed
8.
Zurück zum Zitat Woelber L, Kock L, Gieseking F, et al. Clinical management of primary vulvar cancer. Eur J Cancer. 47:2011:2315–21. PubMedCrossRef Woelber L, Kock L, Gieseking F, et al. Clinical management of primary vulvar cancer. Eur J Cancer. 47:2011:2315–21. PubMedCrossRef
9.
Zurück zum Zitat Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008;108:577–83. PubMedCrossRef Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008;108:577–83. PubMedCrossRef
10.
Zurück zum Zitat de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG. Management of vulvar cancers. Eur J Surg Oncol. 2006;32:825–31. PubMedCrossRef de Hullu JA, van der Avoort IA, Oonk MH, van der Zee AG. Management of vulvar cancers. Eur J Surg Oncol. 2006;32:825–31. PubMedCrossRef
11.
Zurück zum Zitat Boronow RC, Hickman BT, Reagan MT, Smith RA, Steadham RE. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol. 1987;10:171–81. PubMedCrossRef Boronow RC, Hickman BT, Reagan MT, Smith RA, Steadham RE. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer. II. Results, complications, and dosimetric and surgical considerations. Am J Clin Oncol. 1987;10:171–81. PubMedCrossRef
12.
Zurück zum Zitat van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev. 2006;CD003752. van Doorn HC, Ansink A, Verhaar-Langereis M, Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst Rev. 2006;CD003752.
13.
Zurück zum Zitat Kalra JK, Grossman AM, Krumholz BA, et al. Preoperative chemoradiotherapy for carcinoma of the vulva. Gynecol Oncol. 1981;12:256–60. PubMedCrossRef Kalra JK, Grossman AM, Krumholz BA, et al. Preoperative chemoradiotherapy for carcinoma of the vulva. Gynecol Oncol. 1981;12:256–60. PubMedCrossRef
14.
Zurück zum Zitat Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2000;48:1007–13. PubMedCrossRef Montana GS, Thomas GM, Moore DH, et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 2000;48:1007–13. PubMedCrossRef
15.
Zurück zum Zitat Levin W, Goldberg G, Altaras M, Bloch B, Shelton MG. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecol Oncol. 1986;25:20–5. PubMedCrossRef Levin W, Goldberg G, Altaras M, Bloch B, Shelton MG. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecol Oncol. 1986;25:20–5. PubMedCrossRef
16.
Zurück zum Zitat Gerszten K, Selvaraj RN, Kelley J, Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 2005;99:640–4. PubMedCrossRef Gerszten K, Selvaraj RN, Kelley J, Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 2005;99:640–4. PubMedCrossRef
17.
Zurück zum Zitat Coon D, Beriwal S, Heron DE, et al. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. Int J Radiat Oncol Biol Phys. 2008;71:779–83. PubMedCrossRef Coon D, Beriwal S, Heron DE, et al. High-dose-rate Rotte "Y" applicator brachytherapy for definitive treatment of medically inoperable endometrial cancer: 10-year results. Int J Radiat Oncol Biol Phys. 2008;71:779–83. PubMedCrossRef
18.
Zurück zum Zitat Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer. 1996;77:1472–8. PubMedCrossRef Lupi G, Raspagliesi F, Zucali R, et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma. A pilot study. Cancer. 1996;77:1472–8. PubMedCrossRef
19.
Zurück zum Zitat Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group. Int J Radiat Oncol Biol Phys. 1998;42:79–85. PubMedCrossRef Moore DH, Thomas GM, Montana GS, Saxer A, Gallup DG, Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the gynecologic oncology group. Int J Radiat Oncol Biol Phys. 1998;42:79–85. PubMedCrossRef
20.
Zurück zum Zitat Slevin NJ, Pointon RC. Radical radiotherapy for carcinoma of the vulva. Br J Radiol. 1989;62:145–7. PubMedCrossRef Slevin NJ, Pointon RC. Radical radiotherapy for carcinoma of the vulva. Br J Radiol. 1989;62:145–7. PubMedCrossRef
21.
Zurück zum Zitat Perez CA, Grigsby PW, Galakatos A, et al Radiation therapy in management of carcinoma of the vulva with emphasis on conservation therapy. Cancer. 1993;71:3707–16. PubMedCrossRef Perez CA, Grigsby PW, Galakatos A, et al Radiation therapy in management of carcinoma of the vulva with emphasis on conservation therapy. Cancer. 1993;71:3707–16. PubMedCrossRef
22.
Zurück zum Zitat Russell AH, Mesic JB, Scudder SA, et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol. 1992;47:14–20. PubMedCrossRef Russell AH, Mesic JB, Scudder SA, et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol Oncol. 1992;47:14–20. PubMedCrossRef
23.
Zurück zum Zitat Thomas G, Dembo A, DePetrillo A, et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol. 1989;34:263–7. PubMedCrossRef Thomas G, Dembo A, DePetrillo A, et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol Oncol. 1989;34:263–7. PubMedCrossRef
24.
Zurück zum Zitat Wahlen SA, Slater JD, Wagner RJ, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer. 1995;75:2289–94. PubMedCrossRef Wahlen SA, Slater JD, Wagner RJ, et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell carcinoma of the vulva. Cancer. 1995;75:2289–94. PubMedCrossRef
25.
Zurück zum Zitat Berek JS, Heaps JM, Fu YS, Juillard GJ, Hacker NF. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol. 1991;42:197–201. PubMedCrossRef Berek JS, Heaps JM, Fu YS, Juillard GJ, Hacker NF. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol Oncol. 1991;42:197–201. PubMedCrossRef
26.
Zurück zum Zitat Koh WJ, Wallace HJ 3rd, Greer BE, et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys. 1993;26:809–16. PubMedCrossRef Koh WJ, Wallace HJ 3rd, Greer BE, et al. Combined radiotherapy and chemotherapy in the management of local-regionally advanced vulvar cancer. Int J Radiat Oncol Biol Phys. 1993;26:809–16. PubMedCrossRef
27.
Zurück zum Zitat Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995;59:51–6. PubMedCrossRef Eifel PJ, Morris M, Burke TW, Levenback C, Gershenson DM. Prolonged continuous infusion cisplatin and 5-fluorouracil with radiation for locally advanced carcinoma of the vulva. Gynecol Oncol. 1995;59:51–6. PubMedCrossRef
28.
Zurück zum Zitat Cunningham MJ, Goyer RP, Gibbons SK, Kredentser DC, Malfetano JH, Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol. 1997;66:258–61. PubMedCrossRef Cunningham MJ, Goyer RP, Gibbons SK, Kredentser DC, Malfetano JH, Keys H. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol Oncol. 1997;66:258–61. PubMedCrossRef
29.
Zurück zum Zitat Moore DH. Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: are two therapies better than one? Gynecol Oncol. 2009;113:379–83. PubMedCrossRef Moore DH. Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: are two therapies better than one? Gynecol Oncol. 2009;113:379–83. PubMedCrossRef
30.
Zurück zum Zitat Akl A, Akl M, Boike G, Hebert J, Graham J. Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:415–20. PubMedCrossRef Akl A, Akl M, Boike G, Hebert J, Graham J. Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:415–20. PubMedCrossRef
31.
Zurück zum Zitat Evans LS, Kersh CR, Constable WC, Taylor PT. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies. Int J Radiat Oncol Biol Phys. 1988;15:901–6. PubMedCrossRef Evans LS, Kersh CR, Constable WC, Taylor PT. Concomitant 5-fluorouracil, mitomycin-C, and radiotherapy for advanced gynecologic malignancies. Int J Radiat Oncol Biol Phys. 1988;15:901–6. PubMedCrossRef
32.
Zurück zum Zitat Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2000;47:1235–44. PubMedCrossRef Han SC, Kim DH, Higgins SA, Carcangiu ML, Kacinski BM. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int J Radiat Oncol Biol Phys. 2000;47:1235–44. PubMedCrossRef
33.
Zurück zum Zitat Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124:529–33. PubMedCrossRef Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124:529–33. PubMedCrossRef
34.
Zurück zum Zitat Mak RH, Halasz LM, Tanaka CK, et al. Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every 3–4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva. Gynecol Oncol. 2011;120:101–7. PubMedCrossRef Mak RH, Halasz LM, Tanaka CK, et al. Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every 3–4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva. Gynecol Oncol. 2011;120:101–7. PubMedCrossRef
35.
Zurück zum Zitat Tans L, Ansink AC, van Rooij PH, Kleijnen C, Mens JW. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol. 2011;34:22–6. PubMedCrossRef Tans L, Ansink AC, van Rooij PH, Kleijnen C, Mens JW. The role of chemo-radiotherapy in the management of locally advanced carcinoma of the vulva: single institutional experience and review of literature. Am J Clin Oncol. 2011;34:22–6. PubMedCrossRef
36.
Zurück zum Zitat Rogers LJ, Howard B, Van Wijk L, et al. Chemoradiation in advanced vulval carcinoma. Int J Gynecol Cancer. 2009;19:745–51. PubMedCrossRef Rogers LJ, Howard B, Van Wijk L, et al. Chemoradiation in advanced vulval carcinoma. Int J Gynecol Cancer. 2009;19:745–51. PubMedCrossRef
37.
Zurück zum Zitat Mulayim N, Foster Silver D, Schwartz PE, Higgins S. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004;93:659–66. PubMedCrossRef Mulayim N, Foster Silver D, Schwartz PE, Higgins S. Chemoradiation with 5-fluorouracil and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol Oncol. 2004;93:659–66. PubMedCrossRef
38.
Zurück zum Zitat Roberts WS, Kavanagh JJ, Greenberg H, et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract. Gynecol Oncol. 1989;34:183–6. PubMedCrossRef Roberts WS, Kavanagh JJ, Greenberg H, et al. Concomitant radiation therapy and chemotherapy in the treatment of advanced squamous carcinoma of the lower female genital tract. Gynecol Oncol. 1989;34:183–6. PubMedCrossRef
39.
Zurück zum Zitat Roberts WS, Hoffman MS, Kavanagh JJ, et al. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol Oncol. 1991;43:233–6. PubMedCrossRef Roberts WS, Hoffman MS, Kavanagh JJ, et al. Further experience with radiation therapy and concomitant intravenous chemotherapy in advanced carcinoma of the lower female genital tract. Gynecol Oncol. 1991;43:233–6. PubMedCrossRef
40.
Zurück zum Zitat Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol. 2006;60:227–41. PubMedCrossRef Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR. Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer. Crit Rev Oncol Hematol. 2006;60:227–41. PubMedCrossRef
41.
Zurück zum Zitat Deppe G. Chemotherapy of Gynecologic Cancer. 1st ed. New York: Alan R Liss, Inc. 1984. Yordan EL, Bonomi PD, Wilbanks GD. Chemotherapy of vulvar and vaginal neoplasms, pp. 85–101. Deppe G. Chemotherapy of Gynecologic Cancer. 1st ed. New York: Alan R Liss, Inc. 1984. Yordan EL, Bonomi PD, Wilbanks GD. Chemotherapy of vulvar and vaginal neoplasms, pp. 85–101.
42.
Zurück zum Zitat Deppe G. Chemotherapy of Gynecologic. 2nd ed. New York: Alan R Liss, Inc. 1990. Yordan EL, Deppe G, Malviya VK, Bonomi P. Chemotherapy of vulvar and vaginal malignanies, pp. 99–119. Deppe G. Chemotherapy of Gynecologic. 2nd ed. New York: Alan R Liss, Inc. 1990. Yordan EL, Deppe G, Malviya VK, Bonomi P. Chemotherapy of vulvar and vaginal malignanies, pp. 99–119.
43.
Zurück zum Zitat Tomao F, Di Tucci C, Marchetti C, Perniola G, Bellati F, Panici PB. Role of chemotherapy in the management of vulvar carcinoma. Crit Rev Oncol Hematol. 2012;82:25–39. PubMedCrossRef Tomao F, Di Tucci C, Marchetti C, Perniola G, Bellati F, Panici PB. Role of chemotherapy in the management of vulvar carcinoma. Crit Rev Oncol Hematol. 2012;82:25–39. PubMedCrossRef
44.
Zurück zum Zitat Horowitz NS, Olawaiye AB, Borger DR, et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol. 2012;127:141–6. PubMedCrossRef Horowitz NS, Olawaiye AB, Borger DR, et al. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol. 2012;127:141–6. PubMedCrossRef
45.
Zurück zum Zitat Taylor SGt, Murthy AK, Showel JL, et al. Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy. Cancer Treat Rep. 1985;69:933–9. PubMed Taylor SGt, Murthy AK, Showel JL, et al. Improved control in advanced head and neck cancer with simultaneous radiation and cisplatin/5-FU chemotherapy. Cancer Treat Rep. 1985;69:933–9. PubMed
46.
Zurück zum Zitat Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–43. PubMedCrossRef Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 1999;340:1137–43. PubMedCrossRef
47.
Zurück zum Zitat Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53. CrossRef Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 1999;340:1144–53. CrossRef
48.
Zurück zum Zitat Peters WA, 3rd, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13. PubMed Peters WA, 3rd, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 2000;18:1606–13. PubMed
49.
Zurück zum Zitat Cummings B, Keane T, Thomas G, Harwood A, Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer. 1984;54:2062–8. PubMedCrossRef Cummings B, Keane T, Thomas G, Harwood A, Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer. 1984;54:2062–8. PubMedCrossRef
50.
Zurück zum Zitat Cummings BJ. Current management of anal canal cancer. Semin Oncology.2005;32:S. 123–8. CrossRef Cummings BJ. Current management of anal canal cancer. Semin Oncology.2005;32:S. 123–8. CrossRef
51.
Zurück zum Zitat Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum. 1981;24:73–5. PubMedCrossRef Nigro ND, Vaitkevicius VK, Buroker T, Bradley GT, Considine B. Combined therapy for cancer of the anal canal. Dis Colon Rectum. 1981;24:73–5. PubMedCrossRef
52.
Zurück zum Zitat Scheistroen M, Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol. 1993;32:657–61. PubMedCrossRef Scheistroen M, Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol. 1993;32:657–61. PubMedCrossRef
53.
Zurück zum Zitat Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol. 1996;61:321–7. PubMedCrossRef Landoni F, Maneo A, Zanetta G, et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol Oncol. 1996;61:321–7. PubMedCrossRef
54.
Zurück zum Zitat Sebag-Montefiore DJ, McLean C, et al. Treatment of advanced carcinoma of the vulva with chemoradiotherapy—can exenterative surgery be avoided? Int J Gynecol Cancer. 1994;4:150–5. PubMedCrossRef Sebag-Montefiore DJ, McLean C, et al. Treatment of advanced carcinoma of the vulva with chemoradiotherapy—can exenterative surgery be avoided? Int J Gynecol Cancer. 1994;4:150–5. PubMedCrossRef
55.
Zurück zum Zitat Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol. 2006;16:144–51. PubMedCrossRef Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin Radiat Oncol. 2006;16:144–51. PubMedCrossRef
56.
Zurück zum Zitat Beriwal S, Jain SK, Heron DE, de Andrade RS, Lin CJ, Kim H. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer. Int J Radiat Oncol Biol Phys. 2007;67:485–9. PubMedCrossRef Beriwal S, Jain SK, Heron DE, de Andrade RS, Lin CJ, Kim H. Dosimetric and toxicity comparison between prone and supine position IMRT for endometrial cancer. Int J Radiat Oncol Biol Phys. 2007;67:485–9. PubMedCrossRef
57.
Zurück zum Zitat Shimizu Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol. 1990;36:423–7. PubMedCrossRef Shimizu Y, Hasumi K, Masubuchi K. Effective chemotherapy consisting of bleomycin, vincristine, mitomycin C, and cisplatin (BOMP) for a patient with inoperable vulvar cancer. Gynecol Oncol. 1990;36:423–7. PubMedCrossRef
58.
Zurück zum Zitat Durrant KR, Mangioni C, Lacave AJ, et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol. 1990;37:359–62. PubMedCrossRef Durrant KR, Mangioni C, Lacave AJ, et al. Bleomycin, methotrexate, and CCNU in advanced inoperable squamous cell carcinoma of the vulva: a phase II study of the EORTC Gynaecological Cancer Cooperative Group (GCCG). Gynecol Oncol. 1990;37:359–62. PubMedCrossRef
59.
Zurück zum Zitat Achilli C, Palaia I, Perniola G, Donato VD, Marchetti C, Benedetti Panici P. Complete remission after neoadjuvant chemotherapy of an advanced vulvar cancer patient: A case report. J Obstet Gynaecol Res. 2012;38:1036–9. PubMedCrossRef Achilli C, Palaia I, Perniola G, Donato VD, Marchetti C, Benedetti Panici P. Complete remission after neoadjuvant chemotherapy of an advanced vulvar cancer patient: A case report. J Obstet Gynaecol Res. 2012;38:1036–9. PubMedCrossRef
60.
Zurück zum Zitat Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol. 2006;100:53–7. PubMedCrossRef Geisler JP, Manahan KJ, Buller RE. Neoadjuvant chemotherapy in vulvar cancer: avoiding primary exenteration. Gynecol Oncol. 2006;100:53–7. PubMedCrossRef
61.
Zurück zum Zitat Domingues AP, Mota F, Durao M, Frutuoso C, Amaral N, de Oliveira CF. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer. 2010;20:294–8. PubMedCrossRef Domingues AP, Mota F, Durao M, Frutuoso C, Amaral N, de Oliveira CF. Neoadjuvant chemotherapy in advanced vulvar cancer. Int J Gynecol Cancer. 2010;20:294–8. PubMedCrossRef
62.
Zurück zum Zitat Benedetti-Panici P, Greggi S, Scambia G, Salerno G, Mancuso S. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol. 1993;50:49–53. PubMedCrossRef Benedetti-Panici P, Greggi S, Scambia G, Salerno G, Mancuso S. Cisplatin (P), bleomycin (B), and methotrexate (M) preoperative chemotherapy in locally advanced vulvar carcinoma. Gynecol Oncol. 1993;50:49–53. PubMedCrossRef
63.
Zurück zum Zitat Narimatsu A, Okada O. A case of FIGO stage IV A vulvar cancer successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil). Gan To Kagaku Ryoho. 24:1997;1161–5. PubMed Narimatsu A, Okada O. A case of FIGO stage IV A vulvar cancer successfully treated by neoadjuvant chemotherapy with continuous intra-arterial infusion (cisplatin, 5-fluorouracil). Gan To Kagaku Ryoho. 24:1997;1161–5. PubMed
64.
Zurück zum Zitat Wagenaar HC, Colombo N, Vergote I, et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC gynaecological cancer cooperative group study. European organization for research and treatment of cancer. Gynecol Oncol. 2001;81:348–54. PubMedCrossRef Wagenaar HC, Colombo N, Vergote I, et al. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC gynaecological cancer cooperative group study. European organization for research and treatment of cancer. Gynecol Oncol. 2001;81:348–54. PubMedCrossRef
65.
Zurück zum Zitat Aragona AM, Cuneo N, Soderini AH, Alcoba E, Greco A, Reyes C, Lekmann S. Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study. Int J Gynecol Cancer.2012;22:1258–63. PubMedCrossRef Aragona AM, Cuneo N, Soderini AH, Alcoba E, Greco A, Reyes C, Lekmann S. Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study. Int J Gynecol Cancer.2012;22:1258–63. PubMedCrossRef
66.
Zurück zum Zitat Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68:733–40. PubMed Homesley HD, Bundy BN, Sedlis A, Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet Gynecol. 1986;68:733–40. PubMed
67.
Zurück zum Zitat Fons G, Hyde SE, Buist MR, et al. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer. 2009;19:1276–80. PubMedCrossRef Fons G, Hyde SE, Buist MR, et al. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer. 2009;19:1276–80. PubMedCrossRef
68.
Zurück zum Zitat Bellati F, Angioli R, Manci N, et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol. 2005;96:227–31. PubMedCrossRef Bellati F, Angioli R, Manci N, et al. Single agent cisplatin chemotherapy in surgically resected vulvar cancer patients with multiple inguinal lymph node metastases. Gynecol Oncol. 2005;96:227–31. PubMedCrossRef
69.
Zurück zum Zitat Deppe G, Cohen CJ, Bruckner HW. Chemotherapy of squamous cell carcinoma of the vulva: A review. Gynecol Oncol. 1979;7:345–8. PubMedCrossRef Deppe G, Cohen CJ, Bruckner HW. Chemotherapy of squamous cell carcinoma of the vulva: A review. Gynecol Oncol. 1979;7:345–8. PubMedCrossRef
70.
Zurück zum Zitat Trope C, Johnsson JE, Larsson G, Simonsen E. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep. 1980;64:639–42. PubMed Trope C, Johnsson JE, Larsson G, Simonsen E. Bleomycin alone or combined with mitomycin C in treatment of advanced or recurrent squamous cell carcinoma of the vulva. Cancer Treat Rep. 1980;64:639–42. PubMed
71.
Zurück zum Zitat Belinson JL, Stewart JA, Richards AL, McClure M. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas. Gynecol Oncol. 1985;20:387–93. CrossRef Belinson JL, Stewart JA, Richards AL, McClure M. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas. Gynecol Oncol. 1985;20:387–93. CrossRef
72.
Zurück zum Zitat Thigpen JT, Blessing JA, Homesley HD, Lewis GC Jr. Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 1986;23:358–63. PubMedCrossRef Thigpen JT, Blessing JA, Homesley HD, Lewis GC Jr. Phase II trials of cisplatin and piperazinedione in advanced or recurrent squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 1986;23:358–63. PubMedCrossRef
73.
Zurück zum Zitat Muss HB, Bundy BN, Christopherson WA. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. Am J Clin Oncol. 1989;12:142–4. PubMedCrossRef Muss HB, Bundy BN, Christopherson WA. Mitoxantrone in the treatment of advanced vulvar and vaginal carcinoma. A gynecologic oncology group study. Am J Clin Oncol. 1989;12:142–4. PubMedCrossRef
74.
Zurück zum Zitat Witteveen PO, van der Velden J, et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group). Ann Oncol. 2009;20:1511–6. PubMedCrossRef Witteveen PO, van der Velden J, et al. Phase II study on paclitaxel in patients with recurrent, metastatic or locally advanced vulvar cancer not amenable to surgery or radiotherapy: a study of the EORTC-GCG (European Organisation for Research and Treatment of Cancer—Gynaecological Cancer Group). Ann Oncol. 2009;20:1511–6. PubMedCrossRef
75.
Zurück zum Zitat Cormio G, Loizzi V, Gissi F, et al. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology. 2009;7:281–4. CrossRef Cormio G, Loizzi V, Gissi F, et al. Cisplatin and vinorelbine chemotherapy in recurrent vulvar carcinoma. Oncology. 2009;7:281–4. CrossRef
76.
Zurück zum Zitat Han SN, Vergote I, Amant F. Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer. Int J Gynecol Cancer. 2012;22:865–8. PubMedCrossRef Han SN, Vergote I, Amant F. Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer. Int J Gynecol Cancer. 2012;22:865–8. PubMedCrossRef
77.
Zurück zum Zitat Belotte J, Awonuga AO, Bolinjkar R, Alexis M, Tabassum F, Deppe G. Platinum-based combination chemotherapy for the treatment of advanced-stage squamous cell carcinoma of the vulva. Obstet Gynecol. 2012;120:458–60. PubMedCrossRef Belotte J, Awonuga AO, Bolinjkar R, Alexis M, Tabassum F, Deppe G. Platinum-based combination chemotherapy for the treatment of advanced-stage squamous cell carcinoma of the vulva. Obstet Gynecol. 2012;120:458–60. PubMedCrossRef
78.
Zurück zum Zitat Olawaiye A, Lee LM, Krasner C, Horowitz N. Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol. 2007;106:628–30. PubMedCrossRef Olawaiye A, Lee LM, Krasner C, Horowitz N. Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol. 2007;106:628–30. PubMedCrossRef
79.
Zurück zum Zitat Bacha OM, Levesque E, Renaud MC, Lalancette M. A case of recurrent vulvar carcinoma treated with erlotinib, an EGFR inhibitor. Eur J Gynaecol Oncol. 2011;32:423–4. PubMed Bacha OM, Levesque E, Renaud MC, Lalancette M. A case of recurrent vulvar carcinoma treated with erlotinib, an EGFR inhibitor. Eur J Gynaecol Oncol. 2011;32:423–4. PubMed
80.
Zurück zum Zitat Richard SD, Krivak TC, Beriwal S, Zorn KK. Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab. Int J Gynecol Cancer. 2008;18:1132–5. PubMedCrossRef Richard SD, Krivak TC, Beriwal S, Zorn KK. Recurrent metastatic vulvar carcinoma treated with cisplatin plus cetuximab. Int J Gynecol Cancer. 2008;18:1132–5. PubMedCrossRef
81.
Zurück zum Zitat Brustmann H. Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB—1 immunoreactivity. Int J Gynecol Pathol. 2007;6:481–9. CrossRef Brustmann H. Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB—1 immunoreactivity. Int J Gynecol Pathol. 2007;6:481–9. CrossRef
82.
Zurück zum Zitat Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol. 1990;76:381–7. PubMed Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL, Bast RC Jr. Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol. 1990;76:381–7. PubMed
83.
Zurück zum Zitat Johnson GA, Mannel R, Khalifa M, et al. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol. 1997;65:425–9. PubMedCrossRef Johnson GA, Mannel R, Khalifa M, et al. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol. 1997;65:425–9. PubMedCrossRef
84.
Zurück zum Zitat Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2009;27:1069–74. PubMedCrossRef Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman LD. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2009;27:1069–74. PubMedCrossRef
85.
Zurück zum Zitat Monk BJ, Willmott LJ, Sumner DA. Anti-angiogenesis agents in metastatic or recurrent cervical cancer. Gynecol Oncol. 2010;116:1816. CrossRef Monk BJ, Willmott LJ, Sumner DA. Anti-angiogenesis agents in metastatic or recurrent cervical cancer. Gynecol Oncol. 2010;116:1816. CrossRef
Metadaten
Titel
Chemotherapy of vulvar cancer: a review
verfasst von
MD Gunter Deppe
MD Ismail Mert
MD Jimmy Belotte
MD, PhD Ira S. Winer
Publikationsdatum
01.03.2013
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 5-6/2013
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-013-0338-y